ReviewPsychiatric services (Washington, D.C.)2015
The Affordable Care Act: an opportunity for improving care for substance use disorders?
Review in Psychiatric services (Washington, D.C.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Changes in legal referrals to specialty substance use disorder treatment from 2015-2019.Health & justice · 2024Article
- Association of Medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US states.Addiction (Abingdon, England) · 2024Article
- Impact of the Young Adult Dependent Coverage Expansion on Opioid Overdoses and Deaths: a Quasi-Experimental Study.Journal of general internal medicine · 2020Article
- Monitoring opioid addiction and treatment: Do you know if your population is engaged?Drug and alcohol dependence · 2019Article
- The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.Drug and alcohol dependence · 2017Article
- Gender differences in discharge dispositions of emergency department visits involving drug misuse and abuse-2004-2011.Substance abuse treatment, prevention, and policy · 2017Article
- Quality of care measures for the management of unhealthy alcohol use.Journal of substance abuse treatment · 2017Article
- Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?Addiction (Abingdon, England) · 2016Article
- Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.Journal of psychoactive drugsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Patient Protection and Affordable Care Act (ACA) will greatly increase coverage for treatment of substance use disorders. To realize the benefits of this opportunity, it is critical to develop reliable, valid, and feasible measures of quality to ensure that treatment is accessible and of high quality. The authors review the availability of current quality measures for substance use disorder treatment and conclude there is a pressing need for development, validation, and use of quality measures. They provide recommendations for research and policy changes to increase the likelihood that patients, families, and society benefit from the increased coverage provided by the ACA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.